Incredible Digital Sales Aren’t Enough to Boost Bed Bath & Beyond
Bed Bath & Beyond reported its fiscal third quarter financial results before the markets opened on Thursday and investors were not happy.
All Work
Chris Lange
Do Costco December Sales Signal a Return to Highs?
Costco Wholesale has reported its sales results for the month of December.
Citigroup, Goldman Sachs, JPMorgan, Tesla and More Wednesday Afternoon Analyst Calls
Tuesday afternoon’s analyst upgrades and downgrades included Citigroup, Goldman Sachs, JPMorgan and Tesla.
Will More Store Closures Save Macy’s?
Macy’s shares climbed on Wednesday after the company said it would be shuttering more stores.
Petco Could Be the First Billion-Dollar IPO of 2021
Petco intends to sell 48 million shares in an initial public offering valued up to more than $930 million.
Roku, Bank of America, Coca-Cola, Canadian Solar, and More of Tuesday Afternoon’s Analyst Calls
24/7 Wall St. is looking at some big analyst calls that we have seen so far on Tuesday. We have included the most recent analyst call on each stock, as well as a recent…
Citigroup, Gilead, Groupon, Morgan Stanley, Spotify and More Monday Afternoon Analyst Calls
Although the markets may be falling, 24/7 Wall St. is taking a look at some big analyst calls that we have seen so far on Monday.
The Analyst Floodgates Are Open for Blockbuster IPOs Airbnb and DoorDash
Here's what analysts are saying about each of some hop IPOs after the quiet period has lifted.
Why Needham Is Calling for 50% More Upside in This AI Stock
The post-IPO quiet period for C3.ai has ended, and one analyst sees more than 50% more upside in the stock.
SEC Freezes Assets of Crypto Fund Manager Alleged of Fraud
The SEC moved quickly and decisively earlier this week when it filed an emergency action and obtained an order imposing an asset freeze and other emergency relief against Virgil Capital and its affiliated companies.
Is It Still Worth Buying Semiconductors Into 2021?
The question for many investors is whether semiconductor stocks can keep up this rally and keep the markets hitting all-time highs.
Why Analysts Lost Confidence in the Arcturus COVID-19 Vaccine
Arcturus Therapeutics shares took a tumble on Tuesday after the company announced update on its COVID-19 vaccine candidate.
Apple, Boeing, Nike, Airbnb, DoorDash and More Analyst Picks to Buy Into 2021
Analysts have raised their targets and issued some very interesting calls lately on which stocks they think will be major players in the coming year, from Apple to Walmart.
Is Aprea Therapeutics Doomed?
Aprea Therapeutics stock was absolutely crushed to start out the week after the company announced results from its late-stage trial evaluating the safety and efficacy of its treatment for myelodysplastic syndromes.
Why This Recently Approved Prostate Cancer Treatment Could Be Huge for Myovant
Myovant shares shot up on Monday after the company announced a new collaboration with Pfizer for its tumor treatment across a couple of indications.
How Big Is This Setback to Altimmune’s COVID-19 Vaccine Candidate?
Altimmune shares dropped on Thursday after the company announced that it had received an update from the FDA regarding its COVID-19 vaccine candidate.
Tuesday’s Top Afternoon Analyst Calls: Peloton, Biogen, Square, Lockheed Martin and More
Tuesday's midday analyst calls included Peloton Interactive, Biogen, Square and Lockheed Martin.
These Are 2020’s Biggest IPO Losers
Here are some of the biggest IPO losers this year, several of which came public before the pandemic hit.
Is the Newest Company to Hit the EV Scene a Contender?
Aurora Mobile entered the electric vehicles ring on Tuesday and saw its shares nearly double in the premarket.
Will These Top-Performing S&P 500 Stocks Still Be a Buy in 2021?
Here are five of the biggest winners in the S&P 500 so far in 2020. Can they keep up the pace into 2021 as the markets continue to push higher?